Imbalanced/incomplete sequences [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2013-09-18 19:32 (4663 d 16:14 ago) – Posting: # 11520
Views: 9,626

Hi John,

❝ Missing observations ⇒ Does that mean we would encounter problems if not all subjects have data for each treatment? i.e, what if we miss some AUCinf values when kel cannot be determined?


There might be a small bias. However, sequences would have to be extremely imbalanced/incomplete to start hurting. Look at FDA’s replicate example data sets.
nAUC nAUCt is rather a rule than an exception. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
369 visitors (0 registered, 369 guests [including 21 identified bots]).
Forum time: 11:46 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5